Why the study?
High-sensitivity cardiac troponin assays can quantify troponin concentrations with low limits of detection, but their real-world impact on operational metrics and downstream cardiac services in emergency department chest pain patients required investigation.
Does implementation of the hs-cTnI assay reduce hospital admissions, length of stay, and downstream cardiac testing in patients presenting to the emergency department with chest pain?
Observational
Does implementation of the hs-cTnI assay reduce hospital admissions, length of stay, and downstream cardiac testing in patients presenting to the emergency department with chest pain?
Answers are grounded in this paper and cite their sources.
The implementation of high-sensitivity troponin assays in the emergency department for chest pain evaluation significantly reduces hospital admissions, length of stay, and the need for downstream cardiac testing.
BACKGROUND: High-sensitivity cardiac troponin (hs-cTnI) assays can quantify troponin concentrations with low limits of detection, potentially expediting and enhancing myocardial infarction diagnoses. This study investigates the real-world impact of hs-cTnI implementation on operational metrics and downstream cardiac services in patients presenting to the emergency department with chest pain. METHODS AND RESULTS: [lt] 0.001) during the index encounter. CONCLUSION: Implementation of the hs-cTnI assay was associated with reduced hospital admissions, shorter length of stay, and decreases in most downstream cardiac testing.
No takes yet. Share an insight, caveat, or question.
Martin et al. (2025) conducted an observational in Chest pain. High-sensitivity cardiac troponin (hs-cTnI) assay was evaluated on Operational metrics and downstream cardiac services (hospital admissions, length of stay, downstream cardiac testing) (p=<0.001).
Synapse has enriched 10 related papers. Consider them for comparative context: